Effects of BDNF and PEC Nanoparticles on Osteocytes
Open Access
- 10 September 2020
- Vol. 25 (18) , 4151
Abstract
Bone substitute materials loaded with mediators that stimulate fracture healing are demanded in the clinical treatment in trauma surgery and orthopedics. Brain-derived neurotrophic factor (BDNF) enhances the proliferation and differentiation of mesenchymal stem cells into osteoblast. To load the implants with BDNF, a drug delivery system that allows the release of BDNF under spatiotemporal control would improve functionality. Polyelectrolyte complex nanoparticles (PECNP) have been reported as a suitable drug delivery system. The suitability of PECNP in contact with osteocytes as the main cell type of bone is not known so far. Thus, we aimed to verify that BDNF and PECNP loaded with BDNF (PECNP+BDNF) as well as pure PECNP have no negative effects on osteocytes in vitro. Therefore, the murine osteocyte cell line MLO-Y4 was treated with BDNF and PECNP+BDNF. The effects on proliferation were analyzed by the BrdU test (n = 5). The results demonstrated a significant increase in proliferation 24 h after BDNF application, whereas PECNP+BDNF did not lead to significant changes. Thus, we conclude that BDNF is an appropriate mediator to stimulate osteocytes. Since the addition of PECNP did not affect the viability of osteocytes, we conclude that PECNP are a suitable drug delivery system for bone implants.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB/TRR 79 projects B7 and M7)
This publication has 36 references indexed in Scilit:
- Cancer Risk After Use of Recombinant Bone Morphogenetic Protein-2 for Spinal ArthrodesisJournal of Bone and Joint Surgery, 2013
- Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivoInternational Journal of Cancer, 2013
- Inhibition of BDNF in Multiple Myeloma Blocks Osteoclastogenesis via Down-Regulated Stroma-Derived RANKL Expression Both In Vitro and In VivoPLOS ONE, 2012
- Evidence for osteocyte regulation of bone homeostasis through RANKL expressionNature Medicine, 2011
- Matrix-embedded cells control osteoclast formationNature Medicine, 2011
- Brain‐derived neurotrophic factor is a potential osteoclast stimulating factor in multiple myelomaInternational Journal of Cancer, 2011
- In-vitro effects of brain-derived neurotrophic factor on neural progenitor/stem cells from rat hippocampusNeuroReport, 2009
- The yin and yang of neurotrophin actionNature Reviews Neuroscience, 2005
- Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neuronsNature Neuroscience, 2005
- Establishment of an Osteocyte-like Cell Line, MLO-Y4Journal of Bone and Mineral Research, 1997